For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Gimme shelter: Building resilience for the other side
Wednesday 22 April 2020, 02:00 AM

MAS Healthy Practice adviser Fiona Mines
DEAR AUNT MASIE
While the last month has been one of the most challenging in my professional career, it’s also been fantastic to see how the practice team have responded. Can you share some ideas for how we could build on our team’s response and their resilience, for when we come out the other side of the pandemic?
Grateful, Palmerston North
The COVID-19 pandemic has forced an enormous number of changes on the way we all live and work within a very short time.
It hasn’t been easy and a
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.